Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

BACKGROUND: ESR1 mutations have attracted attention as a potentially important marker and treatment target in endocrine therapy-resistant breast cancer patients. The E380Q mutation, which is one of the ESR1 mutations, is associated with estradiol (E2) hypersensitivity, increased DNA binding to the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Sueta, Aiko, Tomiguchi, Mai, Murakami, Keiichi, Omoto, Yoko, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700624/
https://www.ncbi.nlm.nih.gov/pubmed/29166868
http://dx.doi.org/10.1186/s12885-017-3779-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700624/
https://www.ncbi.nlm.nih.gov/pubmed/29166868
http://dx.doi.org/10.1186/s12885-017-3779-2

Ejemplares similares